Product
CYP2C19 genotype guided P2Y12 monotherapy
1 clinical trial
2 indications
Indication
Coronary Artery DiseaseIndication
platelet reactivityClinical trial
Pharmacodynamic Outcomes in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention Treated With an Individualized Treatment STRATEGYStatus: Recruiting, Estimated PCD: 2024-12-01